Learning objectives: Have an understanding of the molecular basis of AML.

Understand use of molecularly targeted therapy for AML.

Session date: 
03/12/2019 - 12:00pm to 1:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Ross L. Levine, MD